Dewpoint Therapeutics and Mitsubishi Tanabe Pharma Corporation (MTPC) have entered a strategic research partnership focusing on the development of the former’s TAR DNA-binding protein 43 (TDP-43 ...

BOSTON and CAMBRIDGE, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Dewpoint Therapeutics and ConcertAI announced the first phase of their Translational Oncology partnership, aligned around Dewpoint’s ...

Biotechnology company Dewpoint Therapeutics is translating condensate science into breakthrough medicine for diseases with high unmet need. Dewpoint has built an artificial intelligence (AI ...

Dewpoint Therapeutics Inc. and Mitsubishi Tanabe Pharma Corp. have entered a research collaboration worth up to $480 million to advance Dewpoint’s novel TDP-43 small-molecule condensate modulator for ...

Under the terms of the agreement, Dewpoint will receive an upfront payment and will be eligible for milestone payments based on specified near-term research and development objectives, with a ...

Pegasystems, Nextiva, Verint, Sterling, Dewpoint and Cloud Ingenuity are among the companies to list open positions for channel-related roles. This month, Sterling, Dewpoint and Cloud Ingenuity ...

BOSTON, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Dewpoint Therapeutics Inc., the leading biotechnology company that develops therapeutics by targeting biomolecular condensates, announced today that it ...